Ramón
Lecumberri Villamediana
Consultor Médico
Universitat Autònoma de Barcelona
Barcelona, EspañaPublications in collaboration with researchers from Universitat Autònoma de Barcelona (11)
2024
-
Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine
European Journal of Clinical Investigation
2022
-
Cancer Histology and Natural History of Patients with Lung Cancer and Venous Thromboembolism
Cancers, Vol. 14, Núm. 17
-
Predictors of use of direct oral anticoagulants in patients with venous thromboembolism: Findings from the Registro Informatizado Enfermedad Tromboembólica registry
Frontiers in Medicine, Vol. 9
2021
-
Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically suspected and confirmed pulmonary embolism
European Respiratory Journal, Vol. 58, Núm. 1
-
PICO questions and DELPHI methodology for the management of venous thromboembolism associated with COVID-19
Viruses, Vol. 13, Núm. 11
2020
-
Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project
Clinical and Applied Thrombosis/Hemostasis, Vol. 26
2019
-
Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry
Orphanet Journal of Rare Diseases, Vol. 14, Núm. 1
2018
-
Cancer-associated thrombosis: Beyond clinical practice guidelines-A multidisciplinary (SEMI-SEOM-SETH) expert consensus
TH Open, Vol. 2, Núm. 4, pp. e373-e386
2015
-
Fondaparinux in the initial and long-term treatment of venous thromboembolism
Thrombosis Research, Vol. 135, Núm. 2, pp. 311-317
2013
2007
-
Clinical outcome of patients with venous thromboembolism and renal insufficiency. Findings from the RIETE registry
Thrombosis and Haemostasis, Vol. 98, Núm. 4, pp. 771-776